I know it works for CHF CLBF, GVHD, Covid Ards for those under 65 and Colitis and will work for any number of inflammatory diseases. That is the nature of our beast.. The problem seems to be defining the trial endpoint for a bioligic.
With in a year? CHF and CLBP are possible. If not with in a year-so what? It works. Whenever the corrupted out FDA is shamed into approving our biologic for one use the dam will burst for many uses.
As Alfred Neuman says " What me worry"? No worries mate.
Ann: S&P DJI Announces March 2022 Quarterly Rebalance, page-50
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.15 |
Change
0.045(4.07%) |
Mkt cap ! $1.313B | |||
| Open | High | Low | Value | Volume |
| $1.08 | $1.16 | $1.08 | $4.681M | 4.170M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 99680 | $1.15 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 31000 | 2 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |